These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5109577)

  • 1. [Intracutaneous smallpox vaccination with a weak pathogenic vaccinia virus ("MVA virus")].
    Stickl H; Hochstein-Mintzel V
    Munch Med Wochenschr; 1971 Aug; 113(35):1149-53. PubMed ID: 5109577
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"].
    Stickl H; Hochstein-Mintzel V; Huber HC
    Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Theoretical and practical principles of smallpox vaccination].
    Schneeweiss B; Rohde W
    Z Arztl Fortbild (Jena); 1971 Nov; 65(22):1157-63. PubMed ID: 4401348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experiences with the 2-stage method of vaccination against smallpox (MVA virus pre-vaccination)].
    Rudkowski Z; Remion J; Saraczyńska E
    Pediatr Pol; 1976 May; 51(5):497-503. PubMed ID: 1272640
    [No Abstract]   [Full Text] [Related]  

  • 5. [Smallpx vaccination].
    Just M
    Schweiz Med Wochenschr; 1968 Mar; 98(13):495-503. PubMed ID: 5700509
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of vaccinia virus from the pharynx of children vaccinated against smallpox.
    Gurvich EB; Braginskaya VP; Shenkman LS; Sokolova AF; Davydova AV
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(1):69-76. PubMed ID: 4473485
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization.
    Talbot TR; Ziel E; Doersam JK; LaFleur B; Tollefson S; Edwards KM
    Clin Infect Dis; 2004 Feb; 38(4):536-41. PubMed ID: 14765347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MVA-vaccine in primovaccination against smallpox after the age of three (author's transl)].
    Schröter W; Stickl H; Idel H; Schlipköter HW
    Zentralbl Bakteriol Mikrobiol Hyg B; 1980 Sep; 171(4-5):309-19. PubMed ID: 7456853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant tumors in smallpox vaccination scars: a report of 24 cases.
    Marmelzat WL
    Arch Dermatol; 1968 Apr; 97(4):400-6. PubMed ID: 4296119
    [No Abstract]   [Full Text] [Related]  

  • 10. Complications of smallpox vaccination, 1968. Results of a statewide survey in Alaska.
    Clark PS; Lane JM
    Calif Med; 1971 Sep; 115(3):7-10. PubMed ID: 5094595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica: severe demyelination occurring years after primary smallpox vaccination.
    Adams JM; Brown WJ; Eberle ED; Vorlty A
    Rev Roum Neurol; 1973; 10(3):227-31. PubMed ID: 4726780
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is the intracutaneous vaccinia test specific?].
    Bodtländer D; Esser I; Wigand R
    Dtsch Med Wochenschr; 1971 May; 96(19):820-3 passim. PubMed ID: 5574352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Utilization of the MVA-immunization schedule from the view point of the public health service].
    Weber HG
    Fortschr Med; 1977 Jun; 95(21):1381-6. PubMed ID: 17567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smallpox vaccination of eczema patients with a strain of attenuated live vaccinia (CVI-78).
    Kempe CH; Fulginiti V; Minamitani M; Shinefield H
    Pediatrics; 1968 Dec; 42(6):980-5. PubMed ID: 5726388
    [No Abstract]   [Full Text] [Related]  

  • 17. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of pharyngeal shedding of vaccinia following smallpox vaccination.
    Talbot TR; Peters J; Wright PF; Edwards KM
    Am J Infect Control; 2007 Sep; 35(7):486-8. PubMed ID: 17765564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in the quality of vaccinia viruses with normal and abnormal post-vaccination course (with neurological complications) (author's transl)].
    Ehrengut W; Sarateanu DE
    Dtsch Med Wochenschr; 1975 Jul; 100(27):1457-61. PubMed ID: 236900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methisazone (Marboran) in the prevention of smallpox and in the treatment of the complications of smallpox vaccination. Review].
    Bianchini C
    Arch Ital Sci Med Trop Parassitol; 1969; 50(1):29-38. PubMed ID: 5770701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.